MARKET

GTH

GTH

Genetron Holdings Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.380
-0.070
-4.83%
Closed 16:00 05/20 EDT
OPEN
1.450
PREV CLOSE
1.450
HIGH
1.500
LOW
1.340
VOLUME
166.89K
TURNOVER
99.84K
52 WEEK HIGH
23.76
52 WEEK LOW
1.250
MARKET CAP
125.03M
P/E (TTM)
-1.6220
1D
5D
1M
3M
1Y
5Y
Do Institutions Own Genetron Holdings Limited (NASDAQ:GTH) Shares?
The big shareholder groups in Genetron Holdings Limited ( NASDAQ:GTH ) have power over the company. Institutions will...
Simply Wall St. · 05/03 13:11
--BTIG Adjusts Genetron Holdings' Price Target to $10 From $17, Keeps Buy Rating
MT Newswires · 04/21 08:00
Genetron Health Receives CE Mark For Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD
Genetron Holdings Limited ((&ldquo, Genetron Health&rdquo, or the &ldquo, Company&rdquo, , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early
Benzinga · 04/19 10:04
Genetron Highlights Co. Presented 17 New Research Results At American Association For Cancer Research Meeting
Genetron Holdings Limited ((&ldquo, Genetron Health&rdquo, or the &ldquo, Company&rdquo, , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early
Benzinga · 04/08 10:02
Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022
BEIJING, April 08, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening p...
GlobeNewswire · 04/08 10:00
Genetron Holdings Announces Publication In Clinical And Translational Medicine Demonstrates Mutation Capsule's Potential In MRD Assay Developments
Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer
Benzinga · 04/07 10:05
ORIC, Unity Biotechnology top healthcare gainers; SELLAS, Pulse Biosciences lead losers' pack
Gainers: ORIC Pharmaceuticals (ORIC) +14%. Unity Biotechnology (UBX) +13%. Applied Therapeutics (APLT) +11%. Genetron (GTH) +11%. Clarus Therapeutics (CRXT) +8%. Losers: SELLAS Life Sciences SLS -39%. Pulse Biosciences (PLSE) -22%. Spero Therapeutics SPRO ...
Seekingalpha · 04/01 14:00
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 04/01 13:11
More
No Data
Learn about the latest financial forecast of GTH. Analyze the recent business situations of Genetron Holdings Ltd through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average GTH stock price target is 4.778 with a high estimate of 5.02 and a low estimate of 4.537.
High5.02
Average4.778
Low4.537
Current 1.380
EPS
Actual
Estimate
-0.22-0.17-0.11-0.06
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 63
Institutional Holdings: 18.67M
% Owned: 20.60%
Shares Outstanding: 90.60M
TypeInstitutionsShares
Increased
12
785.78K
New
12
791.89K
Decreased
15
511.36K
Sold Out
5
1.48M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
About GTH
Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Webull offers kinds of Genetron Holdings Ltd - ADR stock information, including NASDAQ:GTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GTH stock methods without spending real money on the virtual paper trading platform.